首页|期刊导航|医药导报|胆汁酸与肠道菌群代谢相互作用及其对药物性胆汁淤积的影响

胆汁酸与肠道菌群代谢相互作用及其对药物性胆汁淤积的影响OA

Interaction Between Bile Acids and Gut Microbiota and Its Effect on Drug-induced Cholestasis

中文摘要英文摘要

药物性胆汁淤积(DIC)是药物性肝损伤的一种重要亚型,其发病机制比较复杂,临床上仍缺乏有效的治疗方法.胆汁酸(BAs)稳态失衡是 DIC 发生发展的核心驱动因素.近年研究发现,DIC 中 BAs 稳态失衡与肠道菌群失调密切相关.该文梳理了 BAs 失衡对 DIC 发展的影响,重点讨论了 BAs 与肠道菌群相互作用机制:一方面肠道菌群调节 BAs 代谢;另一方面 BAs 反过来塑造菌群结构.同时,分析了该相互作用在 DIC 发生发展的可能机制,包括炎症激活、屏障破坏及信号传导紊乱.探讨了以肠道菌群为靶点的潜在治疗策略,以期为 DIC 的基础研究及临床实践提供思路和参考.

Drug-induced cholestasis(DIC)is an important subtype of drug-induced liver injury,with complex pathogenesis and a lack of effective treatment.The homeostasis imbalance of bile acids(BAs)is a key driving factor in the occurrence and development of DIC.Recent studies have found that dysbiosis of the gut microbiota is closely associated with BAs imbalance in DIC.This article reviews the impact of BAs imbalance on the development of DIC,focusing on the interaction mechanisms between BAs and the gut microbiota:on one hand,the gut microbiota regulates BAs metabolism,and on the other hand,BAs in turn shape the microbiota structure.Additionally,this interaction is analyzed in terms of its potential mechanisms in DIC progression,including inflammation activation,barrier disruption,and signaling pathway disorders.Finally,potential therapeutic strategies targeting the gut microbiota are discussed,aiming to provide insights and references for the basic research and clinical practice of DIC.

刘开玉;张蕊;师少军;刘亚妮

华中科技大学同济医学院附属协和医院药学部,武汉 430022华中科技大学同济医学院附属协和医院药学部,武汉 430022华中科技大学同济医学院附属协和医院药学部,武汉 430022华中科技大学同济医学院附属协和医院药学部,武汉 430022

医药卫生

药物性胆汁淤积胆汁酸肠道菌群药物性肝损伤

Drug-induced cholestasisBile acidsGut microbiotaDrug-induced liver injury

《医药导报》 2026 (9)

1548-1553,6

国家自然科学基金资助项目(82104274、82173902、82474008).

10.3870/j.issn.1004-0781.2026.09.010

评论